Crossmark

The Effect of Therapeutic and Supratherapeutic Oral Doses of Nomegestrol Acetate (NOMAC)/17β-Estradiol (E2) on QTcF Intervals in Healthy Women: Results from a Randomized, Double-Blind, Placebo- and Positive-Controlled Trial

Crossref DOI link: https://doi.org/10.1007/s40261-014-0190-5

Published Online: 2014-04-29

Published Print: 2014-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

de Kam, Pieter-Jan

van Kuijk, Jacqueline

Lillin, Otilia

Post, Teun

Thomsen, Torben
License Information

Text and Data Mining valid from 2014-04-29

Document is current

Any future updates will be listed below